TipRanks
Advertisement
Advertisement

CRDL Stock Latest News

Cardiol Therapeutics Expands Phase III MAVERIC Trial After Early Enrollment Milestone
Company AnnouncementsCardiol Therapeutics Expands Phase III MAVERIC Trial After Early Enrollment Milestone
12d ago
6K
CRDL
Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial
PremiumThe Fly
Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial
12d ago
CRDL
Cardiol Therapeutics Bolsters Cash Runway with $7 Million Warrant Exercise Ahead of Phase III Data
PremiumCompany Announcements
Cardiol Therapeutics Bolsters Cash Runway with $7 Million Warrant Exercise Ahead of Phase III Data
19d ago
CRDL
Cardiol Therapeutics receives over $7M in proceeds from warrant exercise
PremiumThe Fly
Cardiol Therapeutics receives over $7M in proceeds from warrant exercise
19d ago
CRDL
Cardiol Therapeutics Bolsters Governance With Updated Code of Conduct Filing
PremiumCompany Announcements
Cardiol Therapeutics Bolsters Governance With Updated Code of Conduct Filing
20d ago
6K
CRDL
Cardiol Therapeutics Details Long-Term Manufacturing and Development Agreements in September SEC Filing
PremiumCompany AnnouncementsCardiol Therapeutics Details Long-Term Manufacturing and Development Agreements in September SEC Filing
24d ago
6K
CRDL
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus After OSC Review
Premium
Company Announcements
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus After OSC Review
25d ago
6K
CRDL
Cardiol Therapeutics files $150M preliminary base shelf prospectus
Premium
The Fly
Cardiol Therapeutics files $150M preliminary base shelf prospectus
25d ago
CRDL
Cardiol Therapeutics to Showcase Cardiac Drug Pipeline at H.C. Wainwright Conference
PremiumCompany Announcements
Cardiol Therapeutics to Showcase Cardiac Drug Pipeline at H.C. Wainwright Conference
26d ago
CRDL
Cardiol Therapeutics initiated with a Buy at B. Riley
PremiumThe Fly
Cardiol Therapeutics initiated with a Buy at B. Riley
1M ago
CRDL
Cardiol Therapeutics price target raised to $10 from $8 at Canaccord
PremiumThe Fly
Cardiol Therapeutics price target raised to $10 from $8 at Canaccord
2M ago
CRDL
Cardiol Therapeutics Reports Second-Quarter 2026 Interim Results
PremiumCompany Announcements
Cardiol Therapeutics Reports Second-Quarter 2026 Interim Results
2M ago
6K
CRDL
Edward Nash Reaffirms Buy on Cardiol with Unchanged $8 Price Target, Citing Strong MAVERIC Trial Design and Attractive CardiolRx Commercial Prospects
PremiumRatingsEdward Nash Reaffirms Buy on Cardiol with Unchanged $8 Price Target, Citing Strong MAVERIC Trial Design and Attractive CardiolRx Commercial Prospects
2M ago
CRDL
Cardiol Therapeutics to Present Heart Disease Pipeline at Canaccord Genuity Growth Conference
Premium
Company Announcements
Cardiol Therapeutics to Present Heart Disease Pipeline at Canaccord Genuity Growth Conference
2M ago
6K
CRDL
Cardiol Therapeutics’ Phase II Pericarditis Data in JAHA Bolsters Near-Complete Phase III MAVERIC Trial
Premium
Company Announcements
Cardiol Therapeutics’ Phase II Pericarditis Data in JAHA Bolsters Near-Complete Phase III MAVERIC Trial
3M ago
6K
CRDL
Cardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial
PremiumThe Fly
Cardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial
3M ago
CRDL
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
PremiumCompany Announcements
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
3M ago
6K
CRDL
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
PremiumCompany Announcements
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
3M ago
6K
CRDL
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance
PremiumCompany Announcements
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance
3M ago
6K
CRDL
Cardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials
PremiumCompany AnnouncementsCardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials
4M ago
6K
CRDL
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
Premium
Company Announcements
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
5M ago
6K
CRDL
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
Premium
Company Announcements
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
5M ago
6K
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >